Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 648

    1.

    Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.

    Guiducci S, Del Rosso A, Cinelli M, Perfetto F, Livi R, Rossi A, Gabrielli A, Giacomelli R, Iori N, Fibbi G, Del Rosso M, Cerinic MM.

    Arthritis Res Ther. 2005;7(6):R1244-53. Epub 2005 Sep 8.

    PMID:
    16277677
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.

    Del Rosso A, Cinelli M, Guiducci S, Pignone A, Fibbi G, Margheri F, Gabrielli A, Giacomelli R, Coppini A, Del Rosso M, Matucci Cerinic M.

    Rheumatology (Oxford). 2005 Oct;44(10):1255-62. Epub 2005 Jul 5.

    PMID:
    15998634
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.

    Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S.

    J Rheumatol. 2000 Apr;27(4):997-1004.

    PMID:
    10782829
    [PubMed - indexed for MEDLINE]
    4.

    Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.

    Ronday HK, Smits HH, Van Muijen GN, Pruszczynski MS, Dolhain RJ, Van Langelaan EJ, Breedveld FC, Verheijen JH.

    Br J Rheumatol. 1996 May;35(5):416-23.

    PMID:
    8646430
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface.

    Cerinic MM, Generini S, Partsch G, Pignone A, Dini G, Konttinen YT, Del Rosso M.

    Life Sci. 1998;63(6):441-53.

    PMID:
    9718068
    [PubMed - indexed for MEDLINE]
    6.

    Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells.

    Guiducci S, Del Rosso A, Cinelli M, Margheri F, D'Alessio S, Fibbi G, Matucci Cerinic M, Del Rosso M.

    Clin Exp Rheumatol. 2005 May-Jun;23(3):364-72.

    PMID:
    15971425
    [PubMed - indexed for MEDLINE]
    7.

    Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.

    Fibbi G, Pucci M, Grappone C, Pellegrini G, Salzano R, Casini A, Milani S, Del Rosso M.

    Hepatology. 1999 Mar;29(3):868-78.

    PMID:
    10051491
    [PubMed - indexed for MEDLINE]
    8.

    Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients.

    Fibbi G, Barletta E, Dini G, Del Rosso A, Pucci M, Cerletti M, Del Rosso M.

    Lab Invest. 2001 Jan;81(1):27-39.

    PMID:
    11204271
    [PubMed - indexed for MEDLINE]
    9.

    Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.

    Fibbi G, Serni U, Matucci A, Mannoni A, Pucci M, Anichini E, Del Rosso M.

    J Rheumatol. 1994 Dec;21(12):2322-8.

    PMID:
    7699636
    [PubMed - indexed for MEDLINE]
    10.

    The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.

    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.

    Int J Oncol. 2005 Jul;27(1):223-35.

    PMID:
    15942664
    [PubMed - indexed for MEDLINE]
    11.

    Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system.

    Fibbi G, Pucci M, D'Alessio S, Grappone C, Pellegrini G, Salzano R, Casini A, Milani S, Del Rosso M.

    Growth Factors. 2001;19(2):87-100.

    PMID:
    11769974
    [PubMed - indexed for MEDLINE]
    12.

    Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.

    Christensen L, Wiborg Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA.

    Int J Cancer. 1996 May 16;66(4):441-52.

    PMID:
    8635858
    [PubMed - indexed for MEDLINE]
    13.

    Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.

    Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.

    Lab Invest. 1998 Sep;78(9):1109-19.

    PMID:
    9759655
    [PubMed - indexed for MEDLINE]
    14.

    Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.

    Cinelli M, Guiducci S, Del Rosso A, Pignone A, Del Rosso M, Fibbi G, Serratì S, Gabrielli A, Giacomelli R, Piccardi N, Matucci Cerinic M.

    Scand J Rheumatol. 2006 Sep-Oct;35(5):346-50.

    PMID:
    17062432
    [PubMed - indexed for MEDLINE]
    15.

    Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.

    Zheng MH, Fan Y, Panicker A, Smith A, Robertson T, Wysocki S, Robbins P, Papadimitriou JM, Wood DJ.

    Am J Pathol. 1995 Dec;147(6):1559-66.

    PMID:
    7495280
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn).

    Bandinelli F, Bartoli F, Perfetto E, Del Rosso A, Moggi-Pignone A, Guiducci S, Cinelli M, Fatini C, Generini S, Gabrielli A, Giacomelli R, Maddali Bongi S, Abbate R, Del Rosso M, Matucci Cerinic M.

    Clin Exp Rheumatol. 2005 Sep-Oct;23(5):671-7. Erratum in: Clin Exp Rheumatol. 2005 Nov-Dec;23(6):917.

    PMID:
    16173244
    [PubMed - indexed for MEDLINE]
    17.

    Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.

    Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, Booyse FM.

    Alcohol Clin Exp Res. 2001 Feb;25(2):163-70.

    PMID:
    11236828
    [PubMed - indexed for MEDLINE]
    18.

    Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.

    Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.

    Thromb Haemost. 1992 Aug 3;68(2):180-4.

    PMID:
    1412164
    [PubMed - indexed for MEDLINE]
    19.

    Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.

    Schuster WA, Medcalf RL, Kruithof EK.

    Endocrinology. 1993 Oct;133(4):1724-30.

    PMID:
    8404615
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk